自私的癌细胞之间合作的悖论
Jean-Pascal Capp1, Frédéric Thomas2, Andriy Marusyk3
1Toulouse Biotechnology Institute University of Toulouse, INSA, CNRS, INRAE Toulouse France.
Evolutionary applications
|July 26, 2023
概括
传统上被视为自私的癌细胞可能会表现出合作. 这项研究探讨了诸如亲属选择和绿胡子效应等进化机制,解释了瘤发育和转移中的合作行为.
科学领域:
- 进化生物学 进化生物学
- 癌症生物学 癌症生物学
- 遗传学 是一个遗传学.
背景情况:
- 癌细胞通常被认为是为了个人的健康而采取自私的策略.
- 瘤生长涉及复杂的相互作用,包括恶性细胞之间的合作和带状细胞.
- 在癌症中这种明显合作的进化基础仍然不清楚.
研究的目的:
- 探索解释癌细胞之间合作的进化机制.
- 讨论癌症合作如何与合作的一般理论有关.
- 为癌症生物学和治疗策略提出新的见解.
主要方法:
- 审查有关合作演变的当前理论.
- 这些理论应用于癌症的发展.
- 讨论特定的合作机制,如绿胡子效应和健康细胞特征的选择.
主要成果:
- 几种经典的合作理论 (亲属选择,互惠,群体选择) 可能适用于癌症.
- "绿胡子"效应被提出为癌细胞合作的新解释.
- 恶性细胞可能表达或从健康细胞中采用合作性特征.
结论:
- 癌细胞之间的合作是一种可信的进化策略.
- 了解这些合作机制为瘤发生和转移提供了新的视角.
- 这一框架可以为新的癌症预防和治疗策略提供信息.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer
48.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.8K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
What is Cancer?
10.8K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


